The Turkish Fear of Pain Questionnaire
Unknown statusNCT05414513
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Children's chronic pain is a significant condition that affects roughly 25% of children, with approximately 3% of them requiring intense pain therapy. In the adult literature, various scales have been established to assess fear of pain. When these scales are studied, fear of pain has been shown to have a role in adult chronic pain research, but this topic has gotten less attention in pediatric chronic pain research. The Fear of Pain Questionnaire for Children (FOPQ-C) is a questionnaire that addresses this knowledge gap. The purpose of this study is to determine the validity and clinical utility of the Fear of Pain Questionnaire for Children (FOPQ-C) Scale in the Turkish community.
Study details
- Official title
- The Turkish Adaptation, Validity, and Reliability Study of the Fear of Pain Questionnaire (FOPQ-TR)
- Conditions
- Chronic Headache
- Sponsor
- Akdeniz University
- Start date
- 2022-09-08
- Primary completion
- 2023-08-08
- Sex
- All
- Age range
- from 5 Years to 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion criteria of children with chronic pain: (1) Being diagnosed with chronic pain. (2) To have the cognitive ability to answer questions for assessment. (3) Completing the test-retest assessment. (4) To be the native language Turkish. * Exclusion criteria for children with chronic pain: 1. Uncontrollable psychological diseases (eg, attention deficit hyperactivity disorder, autism spectrum disorder, schizophrenia, bipolar disorder, major depressive disorder), specific pathologies, will not be included in the study. 2. Patients who started a new treatment during the study or 6 weeks before the study. 3. Study participants will be instructed not to take analgesics for 48 hours prior to assessments. Inclusion criteria for healthy children: 1. between the ages of 5-18. 2. Not having any psychiatric or neurological diagnosis. 3. To be the native language Turkish. Exclusion criteria for healthy children: 1. Families and children who did not agree to participate in the study. 2. To have received medical treatment for any neuropsychiatric disorder.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05414513